Abiopharma

🔍 Rosa David J. (Director)

Company: INTUITIVE SURGICAL INC (ISRG)

Report Date: 2025-10-24

Detailed Transactions and Holdings:

• Acquired 27,000 shares of Common Stock at $79.6378 per share (Direct)
  Date: 2025-10-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 258,756.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 24,500 shares of Common Stock at $547.5502 per share (Direct)
  Date: 2025-10-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 234,256.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 27,000 shares of Non-Qualified Stock Option (right to buy) at $79.6378 per share (Derivative)
  Date: 2025-10-24 | Code: M | Expires: 2027-02-15 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 11, 2026.
• F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.16 to $550.21 as follows: 1,075 shares sold at $542.16 to $543.10; 1,000 shares sold at $543.23 to $544.22; 1,830 shares sold at $544.30 to $545.06; 1,300 shares sold at $545.33 to $546.15; 2,346 shares sold at $546.34 to $547.30; 6,919 shares sold at $547.37 to $548.37; 7,257 shares sold at $548.40 to $549.40; and 2,773 shares sold at $549.42 to $550.21. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.